Phio Pharmaceuticals Corp. (PHIO) stock
PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.72−0.04 (-4.65%)
Close on Nov 17, 2026Market cap $8.33MP/E –Yield –
Phio Pharmaceuticals operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Phio Pharmaceuticals's operating income for the twelve months ending Jun 30, 2026 was -$13.47M. For fiscal 2025 it was -$9.22M. The highest annual figure on record is -$7.36M in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.22M | – |
| FY2024 | Dec 31, 2024 | -$7.39M | – |
| FY2023 | Dec 31, 2023 | -$10.82M | – |
| FY2022 | Dec 31, 2022 | -$11.46M | – |
| FY2021 | Dec 31, 2021 | -$13.51M | – |
| FY2020 | Dec 31, 2020 | -$8.79M | – |
| FY2019 | Dec 31, 2019 | -$8.99M | – |
| FY2018 | Dec 31, 2018 | -$7.36M | – |
| FY2017 | Dec 31, 2017 | -$14.06M | – |
| FY2016 | Dec 31, 2016 | -$9.02M | – |
| FY2015 | Dec 31, 2015 | -$10.24M | – |
| FY2014 | Dec 31, 2014 | -$8.83M | – |
| FY2013 | Dec 31, 2013 | -$20.95M | – |
| FY2012 | Dec 31, 2012 | -$12.98M | – |
| FY2011 | Dec 31, 2011 | -$12.77M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.27M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.17M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.53M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.51M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.31M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.87M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.67M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.59M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.91M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.21M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.90M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.78M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.60M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.73M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.57M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.52M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.64M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.45M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.74M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.68M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.64M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.46M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.31M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.67M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.36M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.67M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.11M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.06M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.15M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.73M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.49M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.90M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.24M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.99M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.48M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.51M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.08M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.34M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.22M | – |
See a number that looks wrong?